Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of California, San Diego
With
Amgen
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects aged 18-65.
Subjects must have POTS diagnosis (Hyperadrenergic Subtype with NE\> 600pg/ml))
Subjects with no structural heart disease
Subject with no arrhythmias
Subjects with norepinephrine levels greater than 600 pg/ml
Subjects with normal CBC, Metabolic, and thyroid levels
You may not be if
Thyroid or adrenal disorders
Drugs that interfere with Ivabradine (example: Cytochrome P450 drugs)
Presentation of peripheral edema and discolored toes with peripheral autonomic neuropathy. Symptoms include: legs (reduced hair growth, cramps), toes (blue color), legs/feet (wounds, ulcers that do not heal), and muscles (numbness, heaviness)
Subjects who have had a history of systemic illnesses (acute or chronic infectious); autoimmune/ inflammatory disease, cancer, COPD, anemia, diabetes, or psychiatric illness
Subjects with resting heart rate\< 60beats/min, atrial fibrillation, advanced AV blocks, sinus disease, and acute decompensated heart failure and severe hepatic impairment.
Smokers or alcohol abuse
Pregnant or breastfeeding mothers
Woman of childbearing potential who are unwilling to use highly effective contraception during treatment and for an additional one month after discontinuing the study drug